Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Praxis Precision Medicines, Inc. (PRAX) Balance Sheet

As of 2026-06-30 (10-Q), Praxis Precision Medicines, Inc. (PRAX) reported total assets of $1.4B, total liabilities of $49.1M and shareholders' equity of $1.3B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $474.8M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

PRAXPraxis Precision Medicines, Inc.Follow PRAX — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
7.1B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
11 Nov, in 18 days
LineFY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
Latest
Jun 26
Trend
Cash and equivalents0.300.140.060.080.220.360.47
Short-term investments—0.110.040.000.180.240.28
Current assets0.300.290.110.080.400.610.77
Total assets0.300.290.120.090.480.941.39
Current liabilities0.020.040.030.020.040.060.05
Total liabilities0.020.040.040.020.040.060.05
Shareholders' equity0.290.250.080.070.450.881.34

USD billions · SEC XBRL

Praxis Precision Medicines, Inc. — questions

How much cash does Praxis Precision Medicines, Inc. have?
$474.8M in cash and cash equivalents as of 2026-06-30.
What are Praxis Precision Medicines, Inc.'s total assets?
$1.4B as of 2026-06-30.
What is Praxis Precision Medicines, Inc.'s shareholders' equity?
$1.3B as of 2026-06-30.

Every figure on this page comes from Praxis Precision Medicines, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.